Defining reaction mechanisms of threshold phenomena in conformational disease
Defining reaction mechanisms of threshold phenomena in conformational disease
批准号:
8063367
负责人:
Conner Iknokwayyo Sandefur
金额:
$3.36万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2013-03-31
关键词:
Alzheimer&aposs DiseaseAppearanceBehaviorBiochemicalBiological PacemakersCellsCharcot-Marie-Tooth DiseaseComplexComputational algorithmComputer softwareDataDevelopmentDiabetes MellitusDiseaseEventExhibitsGene ExpressionGoalsHomeostasisInsulinIsomerismLaboratoriesLeadLinkMethodsModelingMolecular ConformationMutationPathway interactionsPatientsPatternPhenotypePrion DiseasesProcessProductionProinsulinProteinsQuality ControlReactionRecurrenceStressSystemTestingchemical reactiondiabeticinsightmathematical modelmouse modelneonatal diabetes mellitusnervous system disordernovelpolypeptideprotein aggregateprotein aggregationprotein complexprotein foldingprotein misfoldingprotein structure
中文摘要
描述(由申请人提供):涉及蛋白质正常折叠中断的疾病被称为“构象疾病”。由于突变、压力或随机事件,蛋白质会发生错误折叠。错误折叠的蛋白质形成聚集体,影响天然(旁观者)蛋白质的形态和功能。众所周知,这些对蛋白质稳态的破坏与神经系统和普里恩疾病有关。然而,鲜为人知的是蛋白质错误折叠与某些糖尿病表型之间的联系。蛋白质错误折叠和聚集对天然蛋白质形成和生产的影响机制尚不清楚。在构象疾病中经常观察到的一种现象是阈值现象。细胞聚集水平不知何故从无毒到有毒跨越了一个门槛。我们的长期目标是阐明聚集的易错折叠蛋白影响旁观者蛋白发育的机制(S)。我们的直接目标是进一步描述在构象疾病中观察到的阈值现象所必需的条件。在这里,我们提供了一个一般数学模型的初步数据,该模型描述了错误折叠的蛋白质对旁观者蛋白质生产的影响,以及阈值现象的存在条件。两个目的将研究阈值现象如何在构象疾病中表现:具体目标1:确定导致构象疾病中阈值现象表现的关键反应基序。具体目标2:评估蛋白质通量对构象疾病中天然蛋白质消失的动力学行为的影响。
公共卫生相关性:细胞质量控制过程的中断可能导致错误折叠的蛋白质管理不善,导致有毒蛋白质聚集和疾病。错误折叠蛋白水平的升高和相关的聚集与多种疾病有关,如阿尔茨海默氏症、夏科氏-玛丽牙病和糖尿病。了解蛋白质错误折叠和聚集背后的详细机制将有助于深入了解细胞质量控制以及蛋白质错误折叠疾病患者的潜在治疗方法。
英文摘要
DESCRIPTION (provided by applicant): Diseases involving disruptions in proper protein folding are termed "conformational diseases." Proteins undergo misfolding due to mutation, stress or stochastic events. Misfolded proteins form aggregates and impact native (bystander) protein form and function. These disruptions to protein homeostasis are well known to be associated with neurological and prion diseases. Less known, however is the association between protein misfolding and certain diabetic phenotypes. The mechanisms of the impact of protein misfolding and aggregation on native protein formation and production are not well understood. One often observed occurrence in conformational diseases is a threshold phenomenon. Cellular aggregate levels are somehow driven across a threshold from nontoxic to toxic. Our long range goal is to elucidate the mechanism(s) of the impact of aggregate prone misfolded protein on bystander protein development. Our immediate goal is to further describe the conditions necessary for the threshold phenomenon observed in conformational diseases. Here, we present preliminary data of a general mathematical model describing the impact of misfolded protein on bystander protein production and the conditions for existence of a threshold phenomenon. Two aims will examine how the threshold phenomenon manifests in conformational diseases: Specific Aim 1: Identify the key reaction motifs responsible for the manifestation of threshold phenomena in conformational diseases. Specific Aim 2: Evaluate the effects of protein fluxes on the dynamical behavior of native protein disappearance in conformational diseases.
PUBLIC HEALTH RELEVANCE: A disruption in cellular quality control processes can lead to the mismanagement of misfolded proteins, resulting in toxic protein aggregation and disease. Elevated levels of misfolded protein and associated aggregation are implicated in a variety of diseases such as Alzheimer's, Charcot-Marie-Tooth and diabetes mellitus. Understanding the detailed mechanisms behind protein misfolding and aggregation will lend insight into cellular quality control as well as into potential treatments for patients with protein misfolding diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining reaction mechanisms of threshold phenomena in conformational disease
-
批准号:8265827
-
项目类别:
-
资助金额:$1.36万
-
财政年份:2011
-
负责人:Conner Iknokwayyo Sandefur
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: